Last reviewed · How we verify
NCT05125133: ITENs
Evaluation of Insecticide-treated Eave Nets and Window Screens for Malaria Control in Tanzania.
NA trial testing ITENs + ITWS in Malaria,Falciparum in 1,800 participants. Status unknown.
31 August 2022
Quick facts
| Lead sponsor | Ifakara Health Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,800 |
| Start date | 9 July 2021 |
| Primary completion | 31 August 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Tanzania |
Drugs / interventions tested
- ITENs + ITWS
Conditions studied
- Malaria,Falciparum — all drugs for Malaria,Falciparum →
Sponsor
Ifakara Health Institute
Who can join
6 Months and older, any sex, with Malaria,Falciparum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a household randomized trial of a new tool for house modification, Insecticide-Treated Eave nets (ITENs) in combination with insecticide-treated window screens (ITWS), coated with a dual active ingredient (dual AI): Deltamethrin at 3g AI/kg, which corresponds to 144 mg/m² and PBO synergist at 10g/kg which corresponds to 480 mg/m², as used in the so-called dual-AI LLIN or "resistance breaking" nets for resistance malaria vector control. Four hundred and fifty (450) households with intact walls, opened eaves, and those without screens or nets on the windows in Chalinze district, Tanzania will be eligible and only recruited upon written informed consent. The households will be randomly allocated into two arms: one with ITENs and ITWS installed and the other without. The primary outcome will be malaria parasite detection in household residents aged over 6 months old using a quantitative Polymerase Chain Reaction (qPCR) at approximately 12 months post-installation, coinciding with the long rainy season.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Insecticide-treated eave nets and window screens for malaria control in Chalinze district, Tanzania: a study protocol for a household randomised control trial.
Odufuwa OG, Moore SJ, Mboma ZM, Mbuba E, et al · · 2022 · cited 6× · PMID 35854371 · DOI 10.1186/s13063-022-06408-4 -
A household randomized-control trial of insecticide-treated screening for malaria control in unimproved houses in Tanzania.
Odufuwa OG, Moore SJ, Mboma ZM, Mwanga R, et al · · 2025 · PMID 40484966 · DOI 10.1186/s12936-025-05434-2 -
A household randomised-control trial of insecticide-treated screening for malarial control in unimproved houses in Tanzania
Odufuwa OG, Moore SJ, Mboma ZM, Mwanga R, et al · · 2025 · DOI 10.21203/rs.3.rs-6218916/v1
Verify or expand the search:
- PubMed search for NCT05125133
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malaria,Falciparum
Currently open trials in the same condition.
- NCT06618885 — Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso · Phase 1 · active not recruiting
- NCT07009847 — An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine · recruiting
- NCT06524336 — Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children · active not recruiting
- NCT05978037 — A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines · Phase 1, PHASE2 · active not recruiting
- NCT05790889 — A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. · Phase 1, PHASE2 · recruiting
Other Ifakara Health Institute trials
Trials by the same sponsor.
- NCT06172686 — In-vivo Transmission Model in Semi-immune Adults · Phase 1 · unknown
- NCT04944966 — Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria · Phase 2 · completed
- NCT01930331 — Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05125133 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ifakara Health Institute
- Last refreshed: 2 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05125133.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing